Grants for Small businesses - Health

This funding opportunity provides financial support to a single organization to deliver essential technical assistance to Rural Health Clinics across the U.S., helping them improve healthcare delivery and operational effectiveness in underserved areas.

This funding opportunity supports U.S.-based small businesses in developing innovative diagnostic tools to reduce health disparities among diverse patient populations.

The National Cancer Institute intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for pilot/exploratory research on the confluence of cancer stigma and HIV stigma in HIV-positive individuals diagnosed with cancer. This NOFO will utilize the R21 grant mechanism (clinical trial optional), which is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Up to three (3) R21 awards are expected to be funded as part of the initiative. Research projects will advance the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer; investigate the resultant impact of these dual stigmas on cancer outcomes among PWH with cancer; and promote research in diverse domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated. Pilot interventional research, which addresses modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer, is also suitable for this funding mechanism. The NOFO is expected to be published in late Summer 2024 with an expected application due date in late Fall 2024. Details of a pre-application webinar will be announced after the publication of the NOFO. This Notice is being provided to allow sufficient time for potential applicants with relevant expertise and insights to consider applying for this NOFO. Potential applicants are encouraged to view the presentation of this initiative to the Joint Virtual Meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board available at https://videocast.nih.gov/watch=54859 beginning at 3 hour, 39 minutes. Presentation slides are downloadable at: https://deainfo.nci.nih.gov/advisory/joint/0624/Vanderpool.pdf.

This funding opportunity supports small businesses in the U.S. to develop innovative health solutions that improve outcomes and reduce disparities for minority populations and underserved communities.

This funding opportunity supports innovative research on how environmental toxicants impact RNA modifications and their role in health issues, targeting universities, nonprofits, and for-profit organizations involved in related studies.

This funding opportunity provides financial support to organizations working in Botswana to strengthen laboratory and health systems for effective management of HIV and TB programs.

This funding opportunity provides financial support for organizations to develop and evaluate innovative strategies aimed at preventing and addressing elder abuse and neglect among older adults and individuals with disabilities.

This funding opportunity is designed to support a centralized leadership and coordination center that will oversee a comprehensive study on the health of adults living with HIV and similar individuals, focusing on improving health outcomes and addressing disparities through community engagement and scientific research.

This funding opportunity is designed to support research sites that will enroll patients with Type 1 Diabetes at risk of kidney disease, enabling the study of kidney biopsies to advance understanding and treatment of diabetic nephropathy.

This program provides funding and support to small businesses in Pennsylvania that are historically disadvantaged, helping them access capital and improve their participation in public contracts.

This initiative provides funding opportunities for private sector entities in Jordan to collaborate with USAID in addressing key development challenges, focusing on economic growth, water security, governance, education, and the empowerment of women and youth.

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

The Small Business and Not-For-Profit Support Grant Program, initiated by the City of Chicago and funded through the American Rescue Plan Act, aims to provide financial assistance to small businesses and nonprofits. This program is designed to help these entities recover from economic losses sustained due to the COVID-19 pandemic. The City of Chicago, through its Department of Business Affairs and Consumer Protection (BACP), is seeking a qualified organization to administer this $21.5 million grant program. The primary beneficiaries of this grant program are eligible small businesses and nonprofits located within Chicago. The impact goals are centered around stabilizing their operations, supporting their workforce, and mitigating the long-term economic effects of the pandemic. By providing these funds, the program intends to foster economic resilience within the local business and nonprofit ecosystem. The program's priorities and focus are clearly on economic recovery and stability for the most vulnerable sectors affected by the pandemic. The selection of an administering organization will be based on their understanding of the city contractor's needs, the local small business and nonprofit landscape, and the City of Chicago's processes, ensuring efficient and effective distribution of funds. Expected outcomes include a stabilized small business sector and a stronger nonprofit presence in Chicago, both equipped to navigate future economic challenges. Measurable results would likely involve tracking the number of businesses and nonprofits served, jobs retained or created, and the overall economic recovery indicators within the city. While the specific foundation's strategic priorities and theory of change are not explicitly detailed here, the underlying theory is that direct financial support to these entities will lead to broader economic stability and community well-being.

This Notice of Funding Opportunity (NOFO) invites applications from eligible small businesses to develop solutions for commercialization that can be used to enable regional clinician-to-clinician genomic medicine eConsult services. Specifically, we seek products, such as technologies or services, that will allow for the development and sustainment of eConsult services. Eligible United States small business concerns (SBCs) may submit Small Business Innovation Research (SBIR) Phase I, Direct to Phase II, and Fast-Track grant applications. Small business applicants interested in submitting a Small Business Technology Transfer (STTR) grant application should submit to the related funding opportunity, PAR-24-107. SBIR and STTR are phased programs. The main objective in SBIR and STTR Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. An SBIR and STTR Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the conclusion of an SBIR/STTR Phase II, it is expected that the small business will fully commercialize their product or technology using non-SBIR/STTR funds (either federal or non-federal). Small businesses that are eligible to submit Phase II applications for projects that were supported with a Phase I SBIR or STTR award are expected to submit the regular Phase II application as a "Renewal" application based on the awarded Phase I SBIR or STTR project. Only one Phase II application may be awarded for a specific project supported by a Phase I award. NIH Fast-Track: An NIH SBIR Fast-Track incorporates a submission and review process in which both Phase I and Phase II applications are submitted and reviewed together as one application to reduce or eliminate the funding gap between phases. NIH Direct to Phase II: For small businesses that have already demonstrated scientific and technical merit and feasibility but have not received a Phase I SBIR or STTR for that project, NIH can issue a Direct to Phase II award. The NIH will accept Direct to Phase II applications regardless of the funding source for the proof of principle work on which the proposed Phase II research is based. Direct to Phase II awards should be submitted as “New” applications and not continuations ("Renewal") of Phase I SBIR or STTR projects.

This funding opportunity provides financial support to organizations working in Malawi to implement comprehensive HIV prevention strategies, focusing on reducing new infections and improving health outcomes for targeted populations.

This funding opportunity provides financial support for small businesses to conduct innovative clinical trials related to allergy and infectious diseases, focusing on high-risk studies and unlicensed products.

This grant provides funding to improve primary health care services in Togo by enhancing their quality and community responsiveness, particularly for vulnerable groups like women, children, and people living with HIV/AIDS.

This program provides free technical assistance to small Pennsylvania businesses to help them improve their operations and competitiveness by connecting them with expert resources and solutions for specific technical challenges.

This funding opportunity provides financial support for the development of affordable and culturally appropriate biomedical technologies aimed at reducing healthcare disparities among underserved populations in the United States.

This grant provides financial and technical support to Vermont schools and early childhood education centers to improve student health and nutrition by connecting them with local farmers and enhancing farm to school programs.